Cancer Research UK logo.
SearchDonate
  • Search

A study looking at eribulin for advanced breast cancer

Overview

Cancer types:

Breast cancer

Status:

Results

Phase:

Phase 4

Details

This study wanted to find out more about the chemotherapy drug eribulin as a treatment for breast cancer.

It was open to people with breast cancer that had spread. This was either into the surrounding tissue or to another part of the body.

Cancer that has spread into the surrounding tissue is called . Cancer that has spread to another part of the body is called .

The study was open for people to join between 2013 and 2014. The team published the results in 2022.

Recruitment start: 1 July 2013

Recruitment end: 31 October 2014

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Hartmut Kristeleit

Supported by

Eisai

NIHR Clinical Research Network: Cancer

Last reviewed: 08 Apr 2025

CRUK internal database number: 10960

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.